Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: Results from American College of Surgeons Oncology Group trials Z0010 and Z0011

Journal of Clinical Oncology

Volumn 26, Issue 21, 2008, Pages 3530-3535

  Olson Jr , John A ^a   McCall, Linda M ^a   Beitsch, Peter ^a   Whitworth, Pat W ^a   Reintgen, Douglas S ^a   Blumencranz, Peter W ^a   Leitch, A Marilyn ^a   Saha, Sukamal ^a   Hunt, Kelly K ^a   Giuliano, Armando E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TECHNETIUM 99M;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; INTRAOPERATIVE PERIOD; JOINT LIMITATION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHEDEMA; MAJOR CLINICAL STUDY; MORBIDITY; PARESTHESIA; POSTOPERATIVE PERIOD; PRIMARY TUMOR; PRIORITY JOURNAL; RADIATION DOSE; RANGE OF MOTION; SENTINEL LYMPH NODE BIOPSY; SEROMA; THERAPY DELAY; TREATMENT OUTCOME; WOUND INFECTION; ARM; BREAST TUMOR; JOINT CHARACTERISTICS AND FUNCTIONS; LYMPHADENECTOMY; MULTICENTER STUDY; PATHOLOGY; TIME;

ARM; BREAST NEOPLASMS; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHEDEMA; PARESTHESIA; RANGE OF MOTION, ARTICULAR; SENTINEL LYMPH NODE BIOPSY; SEROMA; TIME;

EID: 49049093658     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.15.5630     Document Type: Article

References (21)

1. Lyman GH, Giuliano AE, Somerfield MR, et al: American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23:7703-7720, 2005
2. Mansel RE, Fallowfield L, Kissin M, et al: Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC Trial. J Natl Cancer Inst 98:599-609, 2006
3. Veronesi U, Paganelli G, Viale G, et al: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546-553, 2003
4. Orr RK: The impact of prophylactic axillary node dissection on breast cancer survival: A Bayesian meta-analysis. Ann Surg Oncol 6:109-116, 1999
5. Bland KI, Scott-Conner CE, Menck H, et al: Axillary dissection in breast-conserving surgery for stage I and II breast cancer: A National Cancer Data Base study of patterns of omission and implications for survival. J Am Coll Surg 188:586-595, 1999; discussion 595-596
6. Harris JR, Osteen RT: Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat 5:17-21, 1985
7. Liljegren G, Holmberg L: Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage I: Results from a randomised trial-Uppsala-Orebro Breast Cancer Study Group. Eur J Cancer 33:193-199, 1997
8. Warmuth MA, Bowen G, Prosnitz LR, et al: Complications of axillary lymph node dissection for carcinoma of the breast: A report based on a patient survey. Cancer 83:1362-1368, 1998
9. Kuehn T, Klauss W, Darsow M, et al: Long-term morbidity following axillary dissection in breast cancer patients: Clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat 64:275-286, 2000
10. Petrek JA, Senie RT, Peters M, et al: Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer 92:1368-1377, 2001
11. Silberman AW, McVay C, Cohen JS, et al: Comparative morbidity of axillary lymph node dissection and the sentinel lymph node technique: Implications for patients with breast cancer. Ann Surg 240:1-6, 2004
12. Wilke LG, McCall LM, Posther KE, et al: Surgical complications associated with sentinel lymph node biopsy: Results from a prospective international cooperative group trial. Ann Surg Oncol 13:491-500, 2006
13. Fleissig A, Fallowfield LJ, Langridge CI, et al: Post-operative arm morbidity and quality of life: Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 95:279-293, 2006
14. Temple LK, Baron R, Cody HS, III, et al: Sensory morbidity after sentinel lymph node biopsy and axillary dissection: A prospective study of 233 women. Ann Surg Oncol 9:654-662, 2002
15. Lucci A, McCall LM, Beitsch PD, et al: Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 25:3657-3663, 2007
16. Posther KE, McCall LM, Blumencranz PW, et al: Sentinel node skills verification and surgeon performance: Data from a multicenter clinical trial for early-stage breast cancer. Ann Surg 242:593-599, 2005; discussion 599-602
17. Brogi E, Torres-Matundan E, Tan LK, et al: The results of frozen section, touch preparation, and cytological smear are comparable for intraoperative examination of sentinel lymph nodes: A study in 133 breast cancer patients. Ann Surg Oncol 12:173-180, 2005
18. Weiser MR, Montgomery LL, Susnik B, et al: Is routine intraoperative frozen-section examination of sentinel lymph nodes in breast cancer worthwhile? Ann Surg Oncol 7:651-655, 2000
19. Rubio IT, Korourian S, Cowan C, et al: Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer. Ann Surg Oncol 5:689-694, 1998
20. Mansel RE, Goyal A: European studies on breast lymphatic mapping. Semin Oncol 31:304-310, 2004
21. Van Zee KJ, Manasseh DM, Bevilacqua JL, et al: A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10:1140-1151, 2003